Tag:FDA Law

Professor Lietzan Speaks on Panel at Supreme Court IP Review

November 6th, 2017

Professor Erika Lietzan recently served as a panelist at the Supreme Court IP Review held at the Chicago-Kent College of Law. She discussed Sandoz, Inc. v. Amgen. Inc., a case decided by the Supreme Court last June.

Read More

Professor Lietzan Named Best Lawyer in FDA Law and Biotechnology Law

August 23rd, 2017

Professor Lietzan has again been named a “Best Lawyer in America” in both FDA Law and Biotechnology Law. This marks the fifth year in a row for FDA Law and the eleventh year in a row for

Read More

Professor Lietzan Discusses Executive Order’s Possible Impact on Food and Drug Administration

February 1st, 2017

Professor Erika Lietzan was quoted at length today in an article published by the Regulatory Affairs Professional Society (RAPS) about the impact of President Trump’s January 30 “two-for-one” executive order on the U.S. Food and Drug Administration

Read More

Latest Edition of The Best Lawyers in America Includes Professor Lietzan

September 16th, 2016

The Best Lawyers in America recently announced that Professor Erika Lietzan was selected to be included in its 23rd edition for her work in biotechnology law and FDA law. Professor Lietzan has been listed in biotechnology law

Read More